InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by LUCAS KENAN, Director. Director active across 2 companies, notably Qumu Corp. In total, 8 filings have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €2m. History available since 11 August 2021. The latest transaction was filed on 18 July 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
250,000 shares0Common Stock, $0.01 par valueSEC:0000919574-24-004081:0
58,066 shares@ US$0.906.3% of flowCommon Stock, $0.01 par valueSEC:0000919574-23-000924:0
757,575 shares@ US$1.3278.9% of flowCommon Stock, $0.01 par valueSEC:0000919574-22-006133:0
Ideal exit: 23 Jul 2023 (T+270)
14,967 shares0Common Stock, $0.01 par valueSEC:0000919574-22-003772:0
100,000 shares@ US$1.5010.6% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-007515
Ideal exit: 12 Sept 2022 (T+270)
100,000 shares@ US$1.5050.0% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-007515:0
Ideal exit: 12 Sept 2022 (T+270)
175,000 shares@ US$2.444750.0% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-005215:0
Ideal exit: 8 May 2022 (T+270)
175,000 shares@ US$2.444746.9% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-005215
Ideal exit: 8 May 2022 (T+270)
8 of 8 declarations
About LUCAS KENAN
Kenan Lucas is a Director at Qumu Corp and Streamline Health Solutions Inc. He plays an important role in the governance of these companies, contributing to strategic decision-making and guiding operations. His experience is valuable in ensuring that the companies meet their commitments to shareholders.
